---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-108988"
form_type: "8-K"
ticker: null
cik: "0001600132"
company_name: "Bellerophon Therapeutics, Inc."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:00:32.918962+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Bellerophon to dissolve and liquidate after Nasdaq delisting; trading suspended Oct 16

## Summary
- Nasdaq will suspend trading of BLPH common stock at open on Oct 16, 2023 after company failed to meet listing conditions.
- Board approved a plan of liquidation and dissolution on Oct 12, 2023, subject to stockholder approval at a special meeting.
- Company will cease business operations and distribute remaining assets to stockholders after paying all claims and obligations.
- Stockholders are not entitled to appraisal rights; stock will be cancelled after final distributions.

## SEC filing metadata
- accession: 0001104659-23-108988
- form_type: 8-K
- cik: 0001600132
- company_name: Bellerophon Therapeutics, Inc.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600132/000110465923108988/0001104659-23-108988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600132/000110465923108988/tm2328395d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-108988
- JSON: https://secwatch.observer/filing/0001104659-23-108988.json
- Plain text: https://secwatch.observer/filing/0001104659-23-108988.txt

## Key facts
- Listing & Compliance Notices
  Bellerophon Therapeutics, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101, 5550(a)(2)
  source text: October 12, 2023, the Company notified the Panel that it will not be able to meet the conditions of the Panel’s decision. Accordingly, on October 12, 2023, the Staff notified the Company that it determined to delist the Company’s shares of common stock from the Nasdaq Capital Market and that trading in the Company’s shares will be suspended at the open of trading on Monday October 16, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1600132/000110465923108988/0001104659-23-108988-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.